drugset / Trial / NCT02025725

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis

NCT02025725

Phase 3 Completed 205 enrolled Evoke Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is provide confirmation of the safety and efficacy of Metoclopramide Nasal Spray compared to placebo in reducing the symptoms of diabetic gastroparesis in adult women.

Timeline

Start
2014-03-27
Primary completion
2016-05-27
Completion
2016-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 10 mg Intranasal

Indications